Millard-Gubler Syndrome – Causes and Treatment
Millard-Gubler Syndrome is a rare neurological condition caused by a lesion in the pons of the brainstem, leading to ipsilateral facial nerve palsy and contralateral hemiplegia.
Things worth knowing about "Millard-Gubler Syndrome"
Millard-Gubler Syndrome is a rare neurological condition caused by a lesion in the pons of the brainstem, leading to ipsilateral facial nerve palsy and contralateral hemiplegia.
What is Millard-Gubler Syndrome?
Millard-Gubler Syndrome is a rare neurological disorder belonging to the group of alternating brainstem syndromes. It results from a unilateral lesion in the pons (part of the brainstem) and was first described in the 19th century by French physicians Auguste Louis Jules Millard and Adolphe-Marie Gubler.
The hallmark of this syndrome is the combination of an ipsilateral (same-side) facial nerve palsy (cranial nerve VII) and a contralateral (opposite-side) hemiparesis or hemiplegia of the body, caused by involvement of the corticospinal tract (pyramidal tract).
Causes
Millard-Gubler Syndrome results from lesions in the caudal (lower) pons affecting the nucleus or fibers of the facial nerve (cranial nerve VII) and the adjacent pyramidal tract fibers. Common causes include:
- Ischemic stroke in the territory of the basilar artery or its branches
- Hemorrhagic stroke (bleeding into the pons)
- Tumors of the brainstem (e.g., gliomas)
- Demyelinating diseases such as multiple sclerosis
- Inflammatory conditions (e.g., encephalitis, abscess)
- Traumatic brain injury
Symptoms
The classic presentation of Millard-Gubler Syndrome includes the following signs:
- Ipsilateral peripheral facial palsy: Paralysis of all facial muscles on the side of the lesion (forehead, eye, mouth), characteristic of a peripheral nerve lesion
- Contralateral hemiparesis or hemiplegia: Weakness or complete paralysis of the limbs on the opposite side of the body, due to damage to the pyramidal tract
- In some cases, an additional ipsilateral abducens palsy (cranial nerve VI), preventing the eye from moving outward
- Possible dysarthria (speech difficulty) due to involvement of motor cranial nerve nuclei
- Occasional nystagmus or gaze palsies
Diagnosis
The diagnosis of Millard-Gubler Syndrome is primarily clinical, based on the characteristic combination of ipsilateral facial palsy and contralateral hemiparesis. The following investigations are used to confirm the diagnosis and identify the underlying cause:
- Magnetic Resonance Imaging (MRI) of the brainstem: the preferred method for visualizing ischemia, hemorrhage, tumors, or demyelinating lesions in the pons
- Computed Tomography (CT) of the head: particularly useful in acute settings to detect hemorrhage
- MR or CT angiography: to assess the cerebral blood vessels
- Neurological examination: detailed assessment of cranial nerve function and motor pathways
- Laboratory tests: complete blood count, coagulation studies, inflammatory markers depending on clinical suspicion
Treatment
Treatment of Millard-Gubler Syndrome depends on the underlying cause:
Ischemic Stroke
In acute ischemic stroke, immediate thrombolysis (clot-dissolving therapy) or mechanical thrombectomy is the priority, provided there are no contraindications. Secondary prevention includes antiplatelet agents or anticoagulants.
Hemorrhagic Stroke
Brainstem hemorrhage requires conservative management or neurosurgical intervention depending on the size and location of the bleed.
Tumor-Related Causes
Depending on the tumor type, surgery, radiation therapy, or chemotherapy may be indicated.
Rehabilitation
Regardless of the underlying cause, intensive neurological rehabilitation is essential for improving quality of life. This includes:
- Physiotherapy to improve motor function
- Occupational therapy to support daily living activities
- Speech and language therapy for speech and swallowing difficulties
- Eye care in cases of incomplete eyelid closure (corneal protection)
Prognosis
The prognosis of Millard-Gubler Syndrome depends on the cause, the extent of the brainstem lesion, and how quickly treatment is initiated. With timely treatment of ischemic stroke, neurological deficits may partially or fully resolve. Severe lesions or delayed treatment can result in permanent disability.
References
- Duus' Topical Diagnosis in Neurology. Baehr M., Frotscher M. Thieme, 5th edition, 2012.
- Brandt T., Dieterich M., Strupp M. - Vertigo and Dizziness. Springer, 2nd edition, 2013.
- World Health Organization (WHO) - Stroke and cerebrovascular disease. Available at: https://www.who.int (accessed 2024).
Building Blocks for a Healthy Life
As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.
Most purchased products
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®Most read entries
3 Posts in this encyclopedia categoryMagnesiumcarbonat
Calorie content
Cologne list
Related search terms: Millard-Gubler Syndrome-en